Covid vaccine stocks jump as new variants emerge
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
Source: cnbc.com
Page 14 - Biontech Se News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biontech Se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biontech Se Today - Breaking & Trending Today
Moderna and BioNTech Both Have Strong Drug pipelines and Plenty of Cash.
Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.
Source: marketwatch.com
BioNTech SE Posts Loss In Q2; Reiterates COVID-19 Vaccine Revenue Guidance
BioNTech SE (BNTX) posted a second-quarter net loss of 190.4 million euros, compared to profit of 1.67 billion euros, last year. Loss per share was 0.79 euros, compared to profit of 6.
Source: rttnews.com
BioNTech Stock Falls as Covid-19 Vaccine Maker Misses Revenue Estimates
Sales drop by more than expected in the second quarter, but BioNTech says its new 'variant-adapted Covid-19 vaccine' is still on track.
Source: marketwatch.com
Stocks making the biggest moves premarket: SOVO, BNTX, TSN
Shares of Rao's parent Sovos Brands' popped 25% in premarket trading on news that Campbell Soup will acquire the pasta sauce maker for $2.33 billion.
Source: cnbc.com